Prospective epidemiological studies have consistently demonstrated that cannabis use is
associated with an increased subsequent risk of both psychotic symptoms and …

Background The use of amphetamines is a global public health concern. We summarise
global data on use of amphetamines and mental health outcomes. Methods A systematic …

Epidemiological evidence demonstrates that cannabis use is associated with an increased
risk of psychotic outcomes, and confirms a dose‐response relationship between the level of …

Objective: The authors investigated the rates of conversion to schizophrenia and bipolar
disorder after a substance-induced psychosis, as well as risk factors for conversion. Method …

Importance Psychosis is a hypothesized consequence of cannabis use. Legalization of
cannabis could therefore be associated with an increase in rates of health care utilization for …

Background Distinguishing between a primary psychotic disorder with concurrent substance
abuse (PPD+ SA) and a substance-induced psychotic disorder (SIPD) can be diagnostically …

Research evidence suggests a dose–response relationship for the association between
cannabis use and risk of psychosis. Such relationship seems to reflect an increased risk of …

Issues Methamphetamine use is a problem for health and criminal justice systems (CJS)
worldwide. Methamphetamine is used at higher rates in CJS‐involved populations than the …

Background Evidence suggests that an overlap exists between the neurobiology of
psychotic disorders and the effects of cannabinoids on neurocognitive and neurochemical …

Background Prisoners have a higher prevalence of substance use disorder (SUD) than the
nonincarcerated population. Many studies report that an SUD increases the likelihood of …